ANTICANCER DRUG CONTAINING CARBON DIOXIDE AS AN ACTIVE INGREDIENT Russian patent published in 2016 - IPC A61K33/00 A61P35/00 A61P35/02 A61P43/00 

Abstract RU 2593848 C2

FIELD: medicine.

SUBSTANCE: described is an anticancer drug containing carbon dioxide as an active ingredient. Agent provides downsizing the tumour metastasis suppression or destruction of tumour, as well as reduced volume or destruction of tumour at sections other than section, wherein carbon dioxide absorbed through the skin by means of a transdermal absorption of carbon dioxide through the skin near the tumour or through skin away from the tumour.

EFFECT: anticancer drug is used in combination with surgical therapy, chemotherapy, radiation therapy or immunotherapy, at that, it is possible to intensify effect or can be reduced side effects compared to their monotherapy or multi-field therapy.

6 cl, 8 tbl, 8 ex, 18 dwg

Similar patents RU2593848C2

Title Year Author Number
TREATING CANCER WITH COMBINATION OF RADIATION THERAPY, CERIUM OXIDE NANOPARTICLES AND CHEMOTHERAPEUTIC AGENT 2015
  • Baker, Cheryl
RU2704811C2
COMBINATIONS OF ANTIBODY DRUG CONJUGATES AND CHEMOTHERAPEUTIC COMPOUNDS AND METHODS FOR USING 2009
  • Berri Linn
  • Fillips Gejl L'Juis
  • Slivkovski Mark Ks.
RU2510272C2
COMBINATIONS OF ANTI-HER2-ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC REMEDIES, AND APPLICATION METHODS 2018
  • Berry, Leanne
  • Phillips, Gail, Lewis
  • Sliwkowski, Mark, X.
RU2781195C2
PHARMACEUTICAL COMPOSITIONS, COMPOUNDS, METHODS OF SYNTHESIS OF COMPOUNDS 1995
  • Chu Chung K.
  • Cheng Jung-Chi
RU2168995C2
COMBINATIONS OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS AND METHODS OF USE 2013
  • Berri Linn
  • Fillips Gejl Lyuis
  • Slivkovski Mark Ks.
RU2671489C2
REINFORSING AGENT FOR RADIATION THERAPY, WHICH INCLUDES PYRIDINE DERIVATIVE AS ACTIVE INGREDIENT 2006
  • Fukusima Masakazu
RU2415670C2
MONOCLONAL ANTIBODIES TO CD44, INTENDED FOR USE IN TREATING SQUAMOUS CELL CARCINOMA OF THE HEAD AND THE NECK 2011
  • Luis A.G. Da-Krus
  • Elizabet Dzhejn Frantsmann
RU2599447C2
AGENT IMPROVING ANTI-CANCER EFFECT AND CONTAINING LIPOSOMAL AGENT CONTAINING OXALIPLATIN, AND ANTI-CANCER AGENT CONTAINING LIPOSOMAL AGENT 2009
  • Isida Tatsukhiro
  • Kivada Khirosi
RU2492863C2
COMBINED THERAPY FOR CANCER TREATMENT 2015
  • Bao, Xingfeng
  • Albu, Diana
  • Woodall-Jappe, Mary
RU2708374C2
COMBINATIONS INCLUDING EPOTHILONES, AND THEIR PHARMACEUTICAL APPLICATION 2002
  • Chehn Tjan'Lin
  • Grili Dajana
  • Rotermel Dzhon Dejvid
  • Vartmann Markus
  • Vud Zhanett Mardzhori
RU2375058C2

RU 2 593 848 C2

Authors

Akisue Tosikhiro

Miva Masakhiko

Uekha Takesi

Tanaka Masaya

Dates

2016-08-10Published

2012-03-22Filed